Conformations of Islet Amyloid Polypeptide Monomers in a Membrane Environment: Implications for Fibril Formation

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Duan, Mojie ^a   Fan, Jue ^a   Huo, Shuanghong ^a  

^a CLARK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; MONOMER;

ARTICLE; MEMBRANE DAMAGE; MOLECULAR DYNAMICS; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN MOTIF; SIMULATION; STRUCTURE ANALYSIS; WILD TYPE;

AMYLOID; CELL MEMBRANE; COMPUTER SIMULATION; DISULFIDES; HUMANS; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; LIPID BILAYERS; LIPIDS; MOLECULAR DYNAMICS SIMULATION; MUTATION; PEPTIDES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLSERINES; PROTEIN CONFORMATION; PROTEINS;

EID: 84868316813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047150     Document Type: Article

References (72)

1. Westermark P, (1972) Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci 77: 91-94.
2. Cooper GJ, (1994) Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 15: 163-201.
3. Hull RL, Westermark GT, Westermark P, Kahn SE, (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89: 3629-3643.
4. Lee SC, Hashim Y, Li JK, Ko GT, Critchley JA, et al. (2001) The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels. Clin Endocrinol (Oxf) 54: 541-546.
5. Sakagashira S, Sanke T, Hanabusa T, Shimomura H, Ohagi S, et al. (1996) Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 45: 1279-1281.
6. Ma Z, Westermark GT, Sakagashira S, Sanke T, Gustavsson A, et al. (2001) Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid 8: 242-249.
7. Sakagashira S, Hiddinga HJ, Tateishi K, Sanke T, Hanabusa T, et al. (2000) S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am J Pathol 157: 2101-2109.
8. Cao P, Tu LH, Abedini A, Levsh O, Akter R, et al. (2012) Sensitivity of Amyloid Formation by Human Islet Amyloid Polypeptide to Mutations at Residue 20. J Mol Biol 421: 282-295.
9. Dupuis NF, Wu C, Shea JE, Bowers MT, (2009) Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor. J Am Chem Soc 131: 18283-18292.
10. Reddy AS, Wang L, Singh S, Ling YL, Buchanan L, et al. (2010) Stable and metastable states of human amylin in solution. Biophys J 99: 2208-2216.
11. Wei L, Jiang P, Xu W, Li H, Zhang H, et al. (2011) The molecular basis of distinct aggregation pathways of islet amyloid polypeptide. J Biol Chem 286: 6291-6300.
12. Nanga RP, Brender JR, Vivekanandan S, Ramamoorthy A, (2011) Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim Biophys Acta 1808: 2337-2342.
13. Patil SM, Xu S, Sheftic SR, Alexandrescu AT, (2009) Dynamic alpha-helix structure of micelle-bound human amylin. J Biol Chem 284: 11982-11991.
14. Brender JR, Salamekh S, Ramamoorthy A, (2011) Membrane Disruption and Early Events in the Aggregation of the Diabetes Related Peptide IAPP from a Molecular Perspective. Acc Chem Res.
15. Westermark P, Andersson A, Westermark GT, (2011) Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 91: 795-826.
16. Anguiano M, Nowak RJ, Lansbury PT Jr, (2002) Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry 41: 11338-11343.
17. Kawahara M, Kuroda Y, Arispe N, Rojas E, (2000) Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 275: 14077-14083.
18. Mirzabekov TA, Lin MC, Kagan BL, (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271: 1988-1992.
19. Quist A, Doudevski I, Lin H, Azimova R, Ng D, et al. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102: 10427-10432.
20. Engel MF, Khemtemourian L, Kleijer CC, Meeldijk HJ, Jacobs J, et al. (2008) Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc Natl Acad Sci U S A 105: 6033-6038.
21. Lee CC, Sun Y, Huang HW, (2012) How type II diabetes-related islet amyloid polypeptide damages lipid bilayers. Biophys J 102: 1059-1068.
22. Hebda JA, Miranker AD, (2009) The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes. Annu Rev Biophys 38: 125-152.
23. Jayasinghe SA, Langen R, (2007) Membrane interaction of islet amyloid polypeptide. Biochim Biophys Acta 1768: 2002-2009.
24. Last NB, Rhoades E, Miranker AD, (2011) Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity. Proc Natl Acad Sci U S A 108: 9460-9465.
25. Zhang Y, Luo Y, Deng Y, Mu Y, Wei G, (2012) Lipid interaction and membrane perturbation of human islet amyloid polypeptide monomer and dimer by molecular dynamics simulations. PLoS One 7: e38191.
26. Apostolidou M, Jayasinghe SA, Langen R, (2008) Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding. J Biol Chem 283: 17205-17210.
27. Nanga RP, Brender JR, Xu J, Hartman K, Subramanian V, et al. (2009) Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J Am Chem Soc 131: 8252-8261.
28. Ling YL, Strasfeld DB, Shim SH, Raleigh DP, Zanni MT, (2009) Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid. J Phys Chem B 113: 2498-2505.
29. Knight JD, Miranker AD, (2004) Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol 341: 1175-1187.
30. Williamson JA, Loria JP, Miranker AD, (2009) Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide. J Mol Biol 393: 383-396.
31. Fu L, Liu J, Yan EC, (2011) Chiral sum frequency generation spectroscopy for characterizing protein secondary structures at interfaces. J Am Chem Soc 133: 8094-8097.
32. Jayasinghe SA, Langen R, (2005) Lipid membranes modulate the structure of islet amyloid polypeptide. Biochemistry 44: 12113-12119.
33. Knight JD, Hebda JA, Miranker AD, (2006) Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. Biochemistry 45: 9496-9508.
34. Rustenbeck I, Matthies A, Lenzen S, (1994) Lipid composition of glucose-stimulated pancreatic islets and insulin-secreting tumor cells. Lipids 29: 685-692.
35. Polyansky AA, Volynsky PE, Nolde DE, Arseniev AS, Efremov RG, (2005) Role of lipid charge in organization of water/lipid bilayer interface: insights via computer simulations. J Phys Chem B 109: 15052-15059 The lipid coordinate and topology files are downloaded from http://model.nmr.ru/files.
36. Hess B, Kutzner C, Spoel DV, Lindahl E, (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4: 435-447.
37. Parrinello M, Rahman A, (1981) Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys 52: 7182-7190.
38. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR, (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81: 3684-3690.
39. Hoover WG, (1985) Canonical dynamics: Equilibrium phase-space distributions. Phys Rev A 31: 1695-1697.
40. Nose S, (1984) A molecular dynamics method for simulations in the canonical ensemble. Mol Phys 52: 255-268.
41. Hess B, Bekker H, Berendsen HJ, Fraaije JG, (1997) LINCS: A linear constraint solver for molecular simulations. J Comp Chem 18: 1463-1472.
42. Darden T, York D, Pedersen L, (1993) Particle mesh Ewald: An N-log(N) method for Ewald sums in large systems. J Chem Phys 98: 10089-10092.
43. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh Ewald method. J Chem Phys 103: 8577-8593.
44. Liu G, Prabhakar A, Aucoin D, Simon M, Sparks S, et al. (2010) Mechanistic studies of peptide self-assembly: transient alpha-helices to stable beta-sheets. J Am Chem Soc 132: 18223-18232.
45. Wolf MG, Hoefling M, Aponte-Santamaria C, Grubmuller H, Groenhof G, (2010) g_membed: Efficient insertion of a membrane protein into an equilibrated lipid bilayer with minimal perturbation. J Comput Chem 31: 2169-2174.
46. Oosterwijk C, Villa A, Mark AE, Gunsteren WF, (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. J Comp Chem 25: 1656-1676.
47. Karplus M, (1959) Contact Electron-Spin Coupling of Nuclear Magnetic Moments. J Chem Phys 30: 11-15.
48. Vuister GW, Bax A, (1993) Quantitative J Correlation: A New Approach for Measuring Homonuclear Three-Bond J(HNHa) Coupling Constants in 15N-Enriched Proteins. J Am Chem Soc 115: 7772-7777.
49. Neal S, Nip AM, Zhang H, Wishart DS, (2003) Rapid and accurate calculation of protein 1H, 13C and 15N chemical shifts. J Biomol NMR 26: 215-240.
50. Wishart DS, Bigam CG, Holm A, Hodges RS, Sykes BD, (1995) 1H, 13C and random coil NMR chemical shifts of the common amino acids.I. Investigations of nearest-neighbor effects. J Biomol NMR 5: 67-81.
51. Allen WJ, Lemkul JA, Bevan DR, (2009) GridMAT-MD: a grid-based membrane analysis tool for use with molecular dynamics. J Comput Chem 30: 1952-1958.
52. Cort JR, Liu Z, Lee GM, Huggins KN, Janes S, et al. (2009) Solution state structures of human pancreatic amylin and pramlintide. Protein Eng Des Sel 22: 497-513.
53. Wiltzius JJ, Sievers SA, Sawaya MR, Eisenberg D, (2009) Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Sci 18: 1521-1530.
54. Wishart DS, Sykes BD, Richards FM, (1992) The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31: 1647-1651.
55. Gray TM, Matthews BW, (1984) Intrahelical hydrogen bonding of serine, threonine and cysteine residues within alpha-helices and its relevance to membrane-bound proteins. J Mol Biol 175: 75-81.
56. Krissinel E, Henrick K, (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60: 2256-2268.
57. Lei H, Wu C, Wang Z, Duan Y, (2006) Molecular dynamics simulations and free energy analyses on the dimer formation of an amyloidogenic heptapeptide from human beta2-microglobulin: implication for the protofibril structure. J Mol Biol 356: 1049-1063.
58. Rivera E, Straub J, Thirumalai D, (2009) Sequence and crowding effects in the aggregation of a 10-residue fragment derived from islet amyloid polypeptide. Biophys J 96: 4552-4560.
59. Xu W, Jiang P, Mu Y, (2009) Conformation preorganization: effects of S20G mutation on the structure of human islet amyloid polypeptide segment. J Phys Chem B 113: 7308-7314.
60. Luca S, Yau WM, Leapman R, Tycko R, (2007) Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 46: 13505-13522.
61. Bedrood S, Li Y, Isas JM, Hegde BG, Baxa U, et al. (2012) Fibril structure of human islet amyloid polypeptide. J Biol Chem 287: 5235-5241.
62. Brender JR, Hartman K, Nanga RP, Popovych N, de la Salud Bea R, et al. (2010) Role of zinc in human islet amyloid polypeptide aggregation. J Am Chem Soc 132: 8973-8983.
63. Shim SH, Gupta R, Ling YL, Strasfeld DB, Raleigh DP, et al. (2009) Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution. Proc Natl Acad Sci U S A 106: 6614-6619.
64. Sapay N, Tieleman DP, (2011) Combination of the CHARMM27 force field with united-atom lipid force fields. J Comput Chem 32: 1400-1410.
65. Volynsky PE, Polyansky AA, Simakov NA, Arseniev AS, Efremov RG, (2005) Effect of lipid composition on the "membrane response" induced by a fusion peptide. Biochemistry 44: 14626-14637.
66. Wüthrich K (1986) NMR of Proteins and Nucleic Acids. New York: John Wiley & Sons.
67. Butterfield SM, Lashuel HA, (2010) Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew Chem Int Ed Engl 49: 5628-5654.
68. Li D-W, Bruschweiler R, (2010) Certification of Molecular Dynamics Trajectories with NMR Chemical Shifts. J Phys Chem Lett 1: 246-248.
69. Liu H, Huo S, (2012) Effects of two solvent conditions on the free energy landscape of the BBL peripheral subunit binding domain. J Phys Chem B 116: 646-652.
70. Reddy AS, Wang L, Lin YS, Ling Y, Chopra M, et al. (2010) Solution structures of rat amylin peptide: simulation, theory, and experiment. Biophys J 98: 443-451.
71. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
72. Petrache HI, Tristram-Nagle S, Gawrisch K, Harries D, Parsegian VA, et al. (2004) Structure and fluctuations of charged phosphatidylserine bilayers in the absence of salt. Biophys J 86: 1574-1586.